5 items4 sources3 stocks
Seeking Alpha-Oct 15, 06:51 PM
Recursion Pharmaceuticals: Sanofi News And Fundraising Sum Up Flawed Bull Thesis (RXRX)
Recursion Pharmaceuticals: Sanofi News And Fundraising Sum Up Flawed Bull Thesis (RXRX) Seeking Alpha
Yahoo Finance / Benzinga-Oct 15, 07:36 PM
Recursion (RXRX) Enters New Growth Phase as Sanofi Kicks Off Drug Collab, Shares Soar
Recursion (RXRX) Enters New Growth Phase as Sanofi Kicks Off Drug Collab, Shares Soar Yahoo Finance
Stocktwits-Oct 15, 06:05 PM
RXRX Stock Heads For Its Best Day In Over A Year – What’s Driving The Rally Today?
RXRX Stock Heads For Its Best Day In Over A Year – What’s Driving The Rally Today? Stocktwits
RXRXequity_markets
SEC EDGAR-Oct 15, 12:00 PM
Recursion Pharmaceuticals, 8-K (1.01, 2.02, 7.01, 8.01, 9.01): entered into a material agreement
Recursion said Sanofi optioned a first immunology development candidate, triggering a $10 million milestone payment and bringing collaboration payments received to $144 million; the candidate is planned to enter Phase 1 trials in 2027, with over $300 million in potential additional milestones and royalties.